about
Enhanced anti-colorectal cancer effects of carfilzomib combined with CPT-11 via downregulation of nuclear factor-κB in vitro and in vivo.Proteasome inhibitor patents (2010 - present).Pharmacophore modeling technique applied for the discovery of proteasome inhibitors.Selective anticancer copper(II)-mixed ligand complexes: targeting of ROS and proteasomes.Multi-output model with Box-Jenkins operators of linear indices to predict multi-target inhibitors of ubiquitin-proteasome pathway.Proteasome Inhibitor YSY01A Abrogates Constitutive STAT3 Signaling via Down-regulation of Gp130 and JAK2 in Human A549 Lung Cancer Cells.
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Recent advances in proteasome inhibitor discovery.
@ast
Recent advances in proteasome inhibitor discovery.
@en
Recent advances in proteasome inhibitor discovery.
@nl
type
label
Recent advances in proteasome inhibitor discovery.
@ast
Recent advances in proteasome inhibitor discovery.
@en
Recent advances in proteasome inhibitor discovery.
@nl
prefLabel
Recent advances in proteasome inhibitor discovery.
@ast
Recent advances in proteasome inhibitor discovery.
@en
Recent advances in proteasome inhibitor discovery.
@nl
P2093
P2860
P1476
Recent advances in proteasome inhibitor discovery.
@en
P2093
Desiree Sagaro
Kenyon Daniel
Melanie Kantor
Rainer Metcalf
Yuri Pevzner
P2860
P304
P356
10.1517/17460441.2013.780020
P407
P577
2013-04-02T00:00:00Z